The Baruch S. Blumberg Institute, identified by EIN 06-1671347, is dedicated to advancing discovery science in the fields of biotechnology, public health, and education, with a specific focus on developing new therapies for viral hepatitis and liver cancer. With an operating budget of $13.3 million and total revenue of $14.5 million for the 2025 filing year, the organization engages in research, educational initiatives, and public health outreach programs to enhance the quality of life for those affected by these diseases. The Institute does not rely on a single funder for 50% or more of its revenue, ensuring a diverse funding base to support its mission. For more information, visit www.blumberginstitute.org.